Flesinoxan: haemodynamic effects in chronically-instrumented conscious dogs.
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/biostudies-other/S-TQST60
下载链接
链接失效反馈官方服务：
资源简介：
n=4 chronically-instrumented conscious male Beagle dogs, dosed with Flesinoxan at 0.5 and 1.25 mg/kg, p.o., successively (wash-out 48h). No PK phase. Parameters measured: haemodynamic parameters (SAP, DAP, MAP, HR, LVSP, LVEDP, +dP/dtmax, -dP/dtmax, +dP/dtmax/P, -dP/dtmax/P, TPR, CO, SV) and ECG parameters (RR, PR, QRS, QT, QTcF and QTcb intervals). Haemodynamic and ECG parameters were measured before administration (T0 baseline) and 30 (T30), 60 (T60), 120 (T120), 180 (T180), 240 (T240) and 360 (T360) min post-administration.
创建时间：
2022-02-14
